Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Depressive Disorders: MDD and Dysthymia

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

Depressive Disorders: Etiology

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

Negative and Cognitive Symptoms of Schizophrenia

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...

Psychological and Sociocultural Causes of Schizophrenia

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Personality Disorders: Paranoid and Schizoid

Personality Disorders: Paranoid and Schizoid

Personality disorders represent enduring cognition, affect, and behavior patterns that significantly deviate from societal norms. These maladaptive traits often lead to difficulties in various domains, including interpersonal relationships, occupational settings, and overall psychological well-being. Paranoid personality disorder and schizoid personality disorder are two distinct conditions marked by odd or eccentric behavior.
Paranoid Personality Disorder
Paranoid personality disorder is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Socio-demographic factors of depressive disorders in India: a comparative appraisal.

Indian journal of psychiatry·2011

Same author

Schizo-affective psychosis : is it an entity?

Indian journal of psychiatry·2011

Same author

Case report : carbamazepine therapy in schizophrenia.

Indian journal of psychiatry·2011

Same author

Psychiatric disorders in non - ulcer dyspepsia.

Indian journal of psychiatry·2011

Same author

Prevalence of soft neurological signs : a study among Indian school boys.

Indian journal of psychiatry·2011

Same author

Impact of substance abuse comorbidity on psychopathology and pattern of remission in mania.

Indian journal of psychiatry·2011

Same journal

Anemia associated with long-acting injectable aripiprazole in an elderly man.

Indian journal of psychiatry·2026

Same journal

Psychiatric comorbidities and treatment patterns in epilepsy: A retrospective review from a tertiary neuropsychiatric clinic.

Indian journal of psychiatry·2026

Same journal

Proposal of 'World Psychiatry Day': The aim is to celebrate psychiatry as the third division of medicine alongside internal medicine and general surgery.

Indian journal of psychiatry·2026

Same journal

A bibliometric assessment of the <i>Indian Journal of Psychiatry</i>: Trends, impact, and collaboration (2009-2024).

Indian journal of psychiatry·2026

Same journal

Narcotic bowel syndrome misdiagnosed as somatoform pain disorder and presenting with opioid use disorder - A case report.

Indian journal of psychiatry·2026

Same journal

From tramadol to pregabalin addiction: A case report of unsupervised substance substitution and temporally improved in craving with fluoxetine.

Indian journal of psychiatry·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 29, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Depressive disorders in schizophrenia.

¹Professor & Head, Dept. of Psychiatry, Kasturba Medical College Hospital, Manipal - 576 119, Karnataka.

Indian Journal of Psychiatry

|September 20, 2011

Summary

This summary is machine-generated.

Depression in schizophrenia may be intrinsic or emerge after neuroleptic treatment. While some patients improve, others develop depression during treatment, suggesting neuroleptics might contribute to depressive disorders in schizophrenia.

More Related Videos

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Related Experiment Videos

Last Updated: May 29, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Area of Science:

Psychiatry
Clinical Psychology

Background:

Depressive mood disorders are a significant concern in schizophrenia.
Understanding the temporal relationship between schizophrenia, depression, and neuroleptic treatment is crucial for patient care.

Purpose of the Study:

To investigate the prevalence and course of depressive disorders in schizophrenia patients.
To examine the impact of neuroleptic treatment on depressive symptoms over time.

Main Methods:

A longitudinal study of 146 schizophrenia patients meeting Research Diagnostic Criteria.
Regular follow-up for at least 6 months, assessing depressive symptoms at illness onset and after 8 weeks of neuroleptic treatment.

Main Results:

No significant difference in overall depression rates at illness onset (49 cases) versus final follow-up (56 cases).
Following 8 weeks of neuroleptic treatment, 47% of depressed patients showed symptom resolution.
Conversely, 53% of patients with depression at follow-up had no prior depressive symptoms, indicating onset post-treatment.

Conclusions:

Depression appears to be an intrinsic feature of schizophrenia.
Neuroleptic treatment may play a role in the causation or exacerbation of depressive disorders in some schizophrenia patients.